Variant report

Variant	esv19505
Chromosome Location	chr15:59888194-59904649
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:101)
CpG islands
(count:122)
Chromatin interactive
region (count:5)
LncRNA
region (count:12)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:101 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr15:59903791-59904170	HepG2	liver:	n/a	n/a
2	BCL3	chr15:59903393-59904359	A549	lung:	n/a	n/a
3	BHLHE40	chr15:59903850-59904160	HepG2	liver:	n/a	n/a
4	BRCA1	chr15:59903860-59904120	Hela-S3	cervix:	n/a	n/a
5	CBX3	chr15:59895941-59896494	HCT-116	colon:	n/a	n/a
6	CHD2	chr15:59903849-59904022	Hela-S3	cervix:	n/a	n/a
7	CHD2	chr15:59903897-59904106	HepG2	liver:	n/a	n/a
8	CTCF	chr15:59902173-59902200	NHEK	skin:	n/a	n/a
9	CTCF	chr15:59898886-59898935	GM10266	blood:	n/a	n/a
10	CTCF	chr15:59891840-59891990	HepG2	liver:	n/a	n/a
11	CTCF	chr15:59902154-59902259	HepG2	liver:	n/a	n/a
12	CTCF	chr15:59902079-59902232	HepG2	liver:	n/a	n/a
13	ELF1	chr15:59903631-59904270	A549	lung:	n/a	n/a
14	ELK1	chr15:59904071-59904206	Hela-S3	cervix:	n/a	n/a
15	EP300	chr15:59903540-59904445	A549	lung:	n/a	n/a
16	EP300	chr15:59903437-59904482	A549	lung:	n/a	n/a
17	EP300	chr15:59886370-59888218	A549	lung:	n/a	n/a
18	EP300	chr15:59888660-59888796	HepG2	liver:	n/a	n/a
19	EP300	chr15:59903865-59904262	HepG2	liver:	n/a	n/a
20	EP300	chr15:59903808-59904227	HepG2	liver:	n/a	n/a
21	EP300	chr15:59903963-59904251	HepG2	liver:	n/a	n/a
22	ETS1	chr15:59903674-59904295	A549	lung:	n/a	chr15:59904136-59904151
23	FOS	chr15:59903872-59904160	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr15:59903855-59904176	MCF10A-Er-Src	breast:	n/a	n/a
25	FOS	chr15:59903843-59904186	MCF10A-Er-Src	breast:	n/a	n/a
26	FOSL2	chr15:59903638-59904267	A549	lung:	n/a	n/a
27	FOSL2	chr15:59903834-59904203	HepG2	liver:	n/a	n/a
28	FOSL2	chr15:59903499-59904609	A549	lung:	n/a	n/a
29	FOXA1	chr15:59903826-59904101	HepG2	liver:	n/a	n/a
30	FOXA1	chr15:59903815-59904134	HepG2	liver:	n/a	n/a
31	FOXA1	chr15:59903761-59904104	HepG2	liver:	n/a	n/a
32	FOXA1	chr15:59903828-59904204	HepG2	liver:	n/a	n/a
33	FOXA2	chr15:59903771-59904070	HepG2	liver:	n/a	n/a
34	FOXA2	chr15:59903671-59904270	A549	lung:	n/a	n/a
35	FOXA2	chr15:59903833-59904261	A549	lung:	n/a	n/a
36	GABPA	chr15:59903547-59904481	A549	lung:	n/a	n/a
37	GATA3	chr15:59903530-59904582	A549	lung:	n/a	n/a
38	HEY1	chr15:59903852-59904139	HepG2	liver:	n/a	n/a
39	JUN	chr15:59903859-59904083	HepG2	liver:	n/a	n/a
40	JUND	chr15:59903793-59904252	A549	lung:	n/a	chr15:59903978-59903989
41	JUND	chr15:59903800-59904105	HepG2	liver:	n/a	chr15:59903978-59903989
42	JUND	chr15:59903788-59904305	A549	lung:	n/a	chr15:59903978-59903989
43	MAFF	chr15:59903851-59904293	HepG2	liver:	n/a	chr15:59904039-59904057
44	MAFK	chr15:59903835-59904297	HepG2	liver:	n/a	chr15:59904045-59904056 chr15:59904043-59904057 chr15:59904045-59904056 chr15:59904040-59904055 chr15:59904044-59904055 chr15:59904044-59904055
45	MAFK	chr15:59903787-59904226	HepG2	liver:	n/a	chr15:59904045-59904056 chr15:59904043-59904057 chr15:59904045-59904056 chr15:59904040-59904055 chr15:59904044-59904055 chr15:59904044-59904055
46	MAFK	chr15:59891514-59891679	HepG2	liver:	n/a	chr15:59891595-59891610
47	MAFK	chr15:59903865-59904234	Hela-S3	cervix:	n/a	chr15:59904045-59904056 chr15:59904043-59904057 chr15:59904045-59904056 chr15:59904040-59904055 chr15:59904044-59904055 chr15:59904044-59904055
48	MAFK	chr15:59891508-59891676	HepG2	liver:	n/a	chr15:59891595-59891610
49	MAX	chr15:59903663-59904409	A549	lung:	n/a	n/a
50	MAX	chr15:59903894-59904125	Hela-S3	cervix:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:59904009-59904059	Hepatocyte	liver:	n/a
2	chr15:59903968-59904018	PFSK-1	brain:	n/a
3	chr15:59904009-59904059	NHDF-neo	bronchial:	n/a
4	chr15:59904009-59904059	IMR90	lung:	fetal
5	chr15:59903968-59904018	SAEC	small airway:	n/a
6	chr15:59904009-59904059	MCF-7	breast:	n/a
7	chr15:59904009-59904059	HCM	heart:	n/a
8	chr15:59903968-59904018	SKMC	muscle:	n/a
9	chr15:59903968-59904018	HCM	heart:	n/a
10	chr15:59903968-59904018	HUVEC	blood vessel:	n/a
11	chr15:59904009-59904059	AG04449	skin:	fetal
12	chr15:59904009-59904059	SK-N-MC	brain:	n/a
13	chr15:59903968-59904018	ovcar-3	ovarian:	n/a
14	chr15:59903968-59904018	ProgFib	skin:	n/a
15	chr15:59903968-59904018	GM06990	blood:	n/a
16	chr15:59903968-59904018	HCT-116	colon:	n/a
17	chr15:59904009-59904059	HIPEpiC	eye:	n/a
18	chr15:59903968-59904018	Hela-S3	cervix:	n/a
19	chr15:59904009-59904059	GM12891	blood:	n/a
20	chr15:59904009-59904059	SAEC	small airway:	n/a
21	chr15:59903968-59904018	HIPEpiC	eye:	n/a
22	chr15:59904009-59904059	BE2_C	brain:	n/a
23	chr15:59903968-59904018	CMK	blood:	n/a
24	chr15:59904009-59904059	BJ	skin:	n/a
25	chr15:59903968-59904018	HepG2	liver:	n/a
26	chr15:59904009-59904059	GM06990	blood:	n/a
27	chr15:59903968-59904018	HNPCEpiC	eye:	n/a
28	chr15:59904009-59904059	SKMC	muscle:	n/a
29	chr15:59904009-59904059	GM19239	blood:	n/a
30	chr15:59904009-59904059	Caco-2	colon:	n/a
31	chr15:59903968-59904018	GM12891	blood:	n/a
32	chr15:59904009-59904059	RPTEC	kidney:	n/a
33	chr15:59903968-59904018	LNCaP	prostate:	n/a
34	chr15:59903968-59904018	NHDF-neo	bronchial:	n/a
35	chr15:59904009-59904059	AG09309	skin:	n/a
36	chr15:59904009-59904059	HMEC	breast:	n/a
37	chr15:59904009-59904059	HPAEpiC	pulmonary alveolar:	n/a
38	chr15:59903968-59904018	Hepatocyte	liver:	n/a
39	chr15:59904009-59904059	SK-N-SH_RA	brain:	n/a
40	chr15:59903968-59904018	A549	lung:	n/a
41	chr15:59904009-59904059	ECC-1	luminal epithelium:	n/a
42	chr15:59903968-59904018	NHBE	bronchial:	n/a
43	chr15:59904009-59904059	HRE	kidney:	n/a
44	chr15:59904009-59904059	HCPEpiC	choroid plexus:	n/a
45	chr15:59903968-59904018	T-47D	breast:	n/a
46	chr15:59904009-59904059	AG09319	gingival:	n/a
47	chr15:59903968-59904018	HRPEpiC	eye:	n/a
48	chr15:59904009-59904059	HNPCEpiC	eye:	n/a
49	chr15:59904009-59904059	AoSMC	blood vessel:	n/a
50	chr15:59903968-59904018	RPTEC	kidney:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr15:59891038..59893878-chr15:59903015..59906504,3	K562	blood:
2	chr15:59885738..59888481-chr15:59900504..59902552,2	MCF-7	breast:
3	chr15:59891038..59893878-chr15:59903015..59906504,3	K562	blood:
4	chr15:59900247..59901916-chr15:59903726..59905241,2	K562	blood:
5	chr15:59891996..59893878-chr15:59903015..59905190,2	K562	blood:

(count:12 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GCNT3-2	chr15:59891842-59891910	NONHSAT044180
2	lnc-GCNT3-2	chr15:59901934-59902067	NONHSAT044178
3	lnc-GCNT3-2	chr15:59904101-59904180	NONHSAT044178
4	lnc-GCNT3-2	chr15:59903591-59903875	NONHSAT044181
5	lnc-GCNT3-2	chr15:59901934-59902067	NONHSAT044179
6	lnc-GCNT3-2	chr15:59904101-59904180	NONHSAT044179
7	lnc-GCNT3-2	chr15:59901934-59902067	NONHSAT044180
8	lnc-GCNT3-2	chr15:59888442-59888553	NONHSAT044179
9	lnc-GCNT3-2	chr15:59888493-59888553	NONHSAT044178
10	lnc-GCNT3-2	chr15:59904101-59904180	NONHSAT044180
11	lnc-GCNT3-2	chr15:59891852-59891910	NONHSAT044181
12	lnc-GCNT3-2	chr15:59901934-59902067	NONHSAT044181

No data

Variant related genes	Relation type
GCNT3	TF binding region
GCNT3	CpG island
ENSG00000140297	chromatin interactions

Extended variants
information (count: 1025 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:1025 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs556587833	chr15:59888196-59888197	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs150762059	chr15:59888213-59888214	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs11852458	chr15:59888220-59888221	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs558194986	chr15:59888223-59888224	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs138047307	chr15:59888251-59888252	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs75135388	chr15:59888259-59888260	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs562274140	chr15:59888281-59888282	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs376138676	chr15:59888291-59888292	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs112715328	chr15:59888296-59888297	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs372386689	chr15:59888300-59888301	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs529475324	chr15:59888302-59888303	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs149576848	chr15:59888333-59888334	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs559788740	chr15:59888345-59888346	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs147275819	chr15:59888360-59888361	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs569686531	chr15:59888364-59888365	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs11852547	chr15:59888378-59888379	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs12901058	chr15:59888409-59888410	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs577994371	chr15:59888426-59888427	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs550025478	chr15:59888443-59888444	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
20	rs185419333	chr15:59888460-59888461	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
21	rs537267158	chr15:59888505-59888506	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
22	rs535600782	chr15:59888516-59888517	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
23	rs547632410	chr15:59888520-59888521	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
24	rs71209368	chr15:59888538-59888539	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
25	rs11071458	chr15:59888539-59888540	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs72751124	chr15:59888548-59888549	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
27	rs545661006	chr15:59888556-59888557	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs16941521	chr15:59888583-59888584	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs555991190	chr15:59888589-59888590	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs574274925	chr15:59888597-59888598	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs541179779	chr15:59888605-59888606	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs559530956	chr15:59888620-59888621	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs577856502	chr15:59888637-59888638	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs545490322	chr15:59888639-59888640	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs544731050	chr15:59888647-59888648	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs563864532	chr15:59888670-59888671	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs140861522	chr15:59888682-59888683	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs144615951	chr15:59888694-59888695	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs572049902	chr15:59888712-59888713	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs371104004	chr15:59888723-59888724	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs76712381	chr15:59888730-59888731	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs373392399	chr15:59888738-59888739	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs561986900	chr15:59888751-59888752	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs115442108	chr15:59888753-59888754	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs547758102	chr15:59888762-59888763	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs190716395	chr15:59888764-59888765	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs147464667	chr15:59888772-59888773	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs191092524	chr15:59888777-59888778	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs570068910	chr15:59888781-59888782	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs183639842	chr15:59888782-59888783	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Cancer	21129771	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Abnormal phenotypes	18644119	CNVD
Cancer	16751803	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Holoprosencephaly	21359414	CNVD
Myelofibrosis	22110671	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Mental retardation	17124404	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:118 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:59882400-59891600	Weak transcription	Small Intestine	intestine
2	chr15:59886000-59889400	Enhancers	Fetal Intestine Small	intestine
3	chr15:59886400-59888200	Enhancers	Osteobl	bone
4	chr15:59886400-59888600	Flanking Active TSS	A549	lung
5	chr15:59886600-59888200	Enhancers	Breast Myoepithelial Primary Cells	Breast
6	chr15:59886600-59889400	Enhancers	Stomach Mucosa	stomach
7	chr15:59886800-59888200	Flanking Active TSS	HepG2	liver
8	chr15:59886800-59888600	Enhancers	Ovary	ovary
9	chr15:59886800-59888800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr15:59886800-59892800	Enhancers	Fetal Intestine Large	intestine
11	chr15:59887400-59889400	Enhancers	Sigmoid Colon	Sigmoid Colon
12	chr15:59887800-59888200	Weak transcription	Gastric	stomach
13	chr15:59887800-59888200	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
14	chr15:59887800-59889800	Enhancers	Colonic Mucosa	Colon
15	chr15:59888000-59888200	Flanking Active TSS	Duodenum Mucosa	Duodenum
16	chr15:59888000-59888800	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
17	chr15:59888200-59888400	Enhancers	Duodenum Mucosa	Duodenum
18	chr15:59888200-59888600	Enhancers	Rectal Mucosa Donor 31	rectum
19	chr15:59888200-59888800	Enhancers	Gastric	stomach
20	chr15:59888200-59889200	Enhancers	HepG2	liver
21	chr15:59888400-59888600	Flanking Active TSS	Duodenum Mucosa	Duodenum
22	chr15:59888600-59888800	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
23	chr15:59888600-59888800	Enhancers	A549	lung
24	chr15:59888600-59889400	Enhancers	Duodenum Mucosa	Duodenum
25	chr15:59888600-59891800	Weak transcription	Ovary	ovary
26	chr15:59888800-59889400	Enhancers	Rectal Mucosa Donor 29	rectum
27	chr15:59888800-59890000	Enhancers	Rectal Mucosa Donor 31	rectum
28	chr15:59889200-59892200	Weak transcription	HepG2	liver
29	chr15:59889400-59890000	Weak transcription	Rectal Mucosa Donor 29	rectum
30	chr15:59889400-59890400	Weak transcription	Fetal Intestine Small	intestine
31	chr15:59889400-59893600	Weak transcription	Duodenum Mucosa	Duodenum
32	chr15:59889800-59891000	Weak transcription	Colonic Mucosa	Colon
33	chr15:59890000-59890200	Enhancers	Rectal Mucosa Donor 29	rectum
34	chr15:59890000-59890400	Weak transcription	Rectal Mucosa Donor 31	rectum
35	chr15:59890200-59891600	Weak transcription	Rectal Mucosa Donor 29	rectum
36	chr15:59890400-59891200	Enhancers	Rectal Mucosa Donor 31	rectum
37	chr15:59890400-59892600	Enhancers	Fetal Intestine Small	intestine
38	chr15:59891200-59891400	Enhancers	Colonic Mucosa	Colon
39	chr15:59891200-59891600	Weak transcription	Rectal Mucosa Donor 31	rectum
40	chr15:59891600-59891800	Enhancers	Small Intestine	intestine
41	chr15:59891600-59892400	Enhancers	Rectal Mucosa Donor 29	rectum
42	chr15:59891600-59892400	Enhancers	Rectal Mucosa Donor 31	rectum
43	chr15:59891800-59892400	Enhancers	Ovary	ovary
44	chr15:59892200-59892600	Enhancers	HepG2	liver
45	chr15:59893800-59896000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
46	chr15:59895000-59897600	ZNF genes & repeats	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr15:59895200-59895800	ZNF genes & repeats	Aorta	Aorta
48	chr15:59896000-59896800	Strong transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
49	chr15:59896400-59896600	ZNF genes & repeats	Duodenum Mucosa	Duodenum
50	chr15:59896600-59897600	Enhancers	Rectal Mucosa Donor 31	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links